Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BJDX |
---|---|---|
09:32 ET | 2726 | 4.89 |
09:34 ET | 200 | 4.87 |
09:36 ET | 1100 | 4.59 |
09:38 ET | 1591 | 4.75 |
09:39 ET | 1993 | 4.625 |
09:41 ET | 2801 | 4.78 |
09:43 ET | 1145 | 4.6201 |
09:45 ET | 100 | 4.77 |
09:48 ET | 935 | 4.8 |
09:50 ET | 1600 | 4.6301 |
09:52 ET | 1730 | 4.76 |
09:54 ET | 16547 | 4.7955 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bluejay Diagnostics Inc | 5.7M | -0.5x | --- |
Dror Ortho-Design Inc | 5.7M | 0.0x | --- |
Arch Therapeutics Inc | 5.1M | -0.3x | --- |
Sharps Technology Inc | 6.5M | -0.8x | --- |
Bionik Laboratories Corp | 6.2M | -0.7x | --- |
Femasys Inc | 4.7M | -0.4x | --- |
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a near-patient testing system for triage and monitoring of disease progression. The Company's Symphony platform is a technology platform that provides measurements of key diagnostic biomarkers found in whole blood. The Symphony analyzer orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The Company's first product candidate, an IL-6 test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices (IVDs) market, including sepsis, cardio-metabolic diseases, cancer, and other diseases that require rapid tests.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-10.54 |
Book Value | $11.42 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.